InvestSMART

Biome Australia Limited (ASX: BIO) - Announcements

- Current share price for BIO : $0.285

ASX company news and announcements for Biome Australia Limited (BIO) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Biome Australia Limited (BIO) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Biome Australia Limited (BIO), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Biome Australia Limited (BIO)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$65 Application for quotation of securities - BIO 14 Mar 2022 10:07AM $0.096 $0.285 risen by 196.88%
$65 Investor Presentation 9 Mar 2022 8:27AM $0.095 $0.285 risen by 200%
$65 Release of Restricted Securities from Escrow 2 Mar 2022 4:37PM $0.090 $0.285 risen by 216.67%
$65 Application for quotation of securities - BIO 1 Mar 2022 1:04PM $0.090 $0.285 risen by 216.67%
$65 Record H1 sales deliver 98% revenue growth 28 Feb 2022 8:15AM $0.091 $0.285 risen by 213.19%
$65 Appendix 4D and Half Yearly Report 28 Feb 2022 8:13AM $0.091 $0.285 risen by 213.19%
$65 Ethics approval received for Biome Daily Kids clinical trial 24 Feb 2022 9:31AM $0.097 $0.285 risen by 193.81%
$65 Biome Clinical Development Update 21 Feb 2022 9:18AM $0.099 $0.285 risen by 187.88%
$65 Release of Restricted Securities from Escrow 18 Feb 2022 4:21PM $0.099 $0.285 risen by 187.88%
$65 Supplementary announcement Acne clinical trial 14 Feb 2022 8:33AM $0.097 $0.285 risen by 193.81%
$65 Successful acne clinical trial result with product to launch 9 Feb 2022 9:58AM $0.100 $0.285 risen by 185%
$65 Clinical trial on asthma sufferers validates Biome probiotic 2 Feb 2022 9:17AM $0.105 $0.285 risen by 171.43%
$65 Notification of cessation of securities - BIO 1 Feb 2022 1:21PM $0.105 $0.285 risen by 171.43%
$65 Notification of cessation of securities - BIO 1 Feb 2022 1:20PM $0.105 $0.285 risen by 171.43%
$65 Quarterly Activities & Cashflow Report 24 Jan 2022 9:20AM $0.110 $0.285 risen by 159.09%
$65 Application for quotation of securities - BIO 11 Jan 2022 2:24PM $0.115 $0.285 risen by 147.83%
$65 Release of Restricted Securities from Escrow 4 Jan 2022 12:00PM $0.120 $0.285 risen by 137.50%
$65 Change of Director's Interest Notice 13 Dec 2021 9:19AM $0.105 $0.285 risen by 171.43%
$65 Results of Meeting 10 Dec 2021 1:35PM $0.100 $0.285 risen by 185%
$65 Change of Director's Interest Notice 9 Dec 2021 2:58PM $0.100 $0.285 risen by 185%
$65 Investor Update 3 Dec 2021 8:24AM $0.110 $0.285 risen by 159.09%
$65 Investor Presentation 3 Dec 2021 8:23AM $0.110 $0.285 risen by 159.09%
$65 Annual General Meeting 1 Dec 2021 1:28PM $0.115 $0.285 risen by 147.83%
$65 Biome Australia Commences Trading on the ASX 30 Nov 2021 9:33AM n/a $0.285 n/a
$65 Initial Director's Interest Notice x 3 30 Nov 2021 9:03AM n/a $0.285 n/a

276 - 300 of 314 results

Page 12 of 13

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.